Literature DB >> 6520044

Canine gastrocnemius disuse atrophy: resistance to paralysis by dimethyl tubocurarine.

G A Gronert, R S Matteo, S Perkins.   

Abstract

Ten dogs developed unilateral gastrocnemius disuse atrophy after unilateral hindlimb immobilization in a cast for 25 days. Dose-response curves to dimethyl tubocurarine (MTC) were determined during anesthesia with pentobarbital sodium-N2O. Bolus and continuous infusion increments of MTC every 30 min provided steady-state blood levels at each stage of paralysis. Both gastrocnemius tendons were sectioned and attached to transducers. Both sciatic nerves were stimulated every 30 min: 2 Hz for 2 s, a 15-s pause, 50 Hz for 2 s. Dose-response curves, computer calculated by nonlinear regression using a sigmoid maximal effect model of the Hill equation, were parallel for the data relating blocking of tetanus to dose of MTC. The 50% paralyzing dose (tetanus) for control vs. casted gastrocnemius muscle was 64 vs. 813 mg/kg; corresponding plasma concentrations were 0.12 vs. 2.0 micrograms/ml. Thus in vivo simultaneous tension measurements of both gastrocnemius muscles, one casted and one uncasted, demonstrated resistance to paralysis by MTC in muscle with disuse atrophy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6520044     DOI: 10.1152/jappl.1984.57.5.1502

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  3 in total

Review 1.  Neuromuscular blocking drugs: practical aspects of research in the intensive care unit.

Authors:  N J Harper
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

2.  Mediators of burn-induced neuromuscular changes in mice.

Authors:  J F Tomera; J Martyn
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

3.  Prolonged duration of succinylcholine in patients receiving anticonvulsants: evidence for mild up-regulation of acetylcholine receptors?

Authors:  A T Melton; J F Antognini; G A Gronert
Journal:  Can J Anaesth       Date:  1993-10       Impact factor: 5.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.